GFM Network News


Bayer CEO Werner Baumann speaks during the company’s annual general shareholders’ meeting in Bonn, Germany on April 26, 2019. (Photo: Reuters/Wolfgang Rattay)

Investors call for reprieve for Bayer bosses after AGM rebuke

Reading Time: 2 minutes Frankfurt | Reuters — Three of Bayer’s largest German investors said the drugmaker’s embattled management needed to stay at the helm to avoid further upheaval, despite their unease over a share price slump in the wake of the US$63 billion Monsanto takeover. The backing for CEO Werner Baumann comes after an unprecedented rebuke at the […] Read more

Bayer CEO Werner Baumann speaks during the company’s annual general shareholders’ meeting in Bonn, Germany on April 26, 2019. (Photo: Reuters/Wolfgang Rattay)

Bayer shareholders vent ire over Monsanto-linked stock rout

Reading Time: 2 minutes Bonn | Reuters — Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s US$63 billion takeover of seed and chemical firm Monsanto. Several large investors said they will not support aspirin invesotr Bayer’s management in a key vote scheduled for the end of its […] Read more


(Dave Bedard photo)

Bayer reaps profit lift from Monsanto

Reading Time: 2 minutes Leverkusen, Germany | Reuters –– Bayer’s US$63 billion purchase of seed and chemical firm Monsanto made its mark on the German company’s fourth quarter earnings on Wednesday, lifting profit and boding well for the peak season of its enlarged agriculture business. However, mounting litigation risks related to Monsanto still cast a pall over an adjusted […] Read more



(Bayer.com)

Ag trade flows may change amid trade dispute, Bayer says

Reading Time: 2 minutes Monheim | Reuters — Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities. The head of Bayer’s crop science division told Reuters his company could even benefit if U.S. farmers switched […] Read more

Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

With drugs pipeline in focus, Bayer seen considering cuts

Reading Time: 3 minutes Frankfurt | Reuters — Bayer is considering job cuts and outsourcing as part of a wide-ranging review of drug research and development that will last until at least November, a person familiar with the company told Reuters. The prospect of “very tangible changes” contributed to a decision by key board members to extend the contract […] Read more


(Bayer.com)

Roundup cancer verdict sends Bayer shares sliding

Reading Time: 3 minutes     Frankfurt | Reuters — Bayer shares plunged as much as 14 per cent on Monday, losing about US$14 billion in value, after newly acquired Monsanto was ordered to pay US$289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict […] Read more

(Dave Bedard photo)

With deal to close this week, Bayer to retire Monsanto name

Reading Time: 2 minutes Frankfurt | Reuters — Germany’s Bayer will wrap up the US$63 billion takeover of Monsanto on Thursday and also retire the U.S. seed and chemical firm’s 117-year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. “Bayer will remain the company name. Monsanto will no […] Read more


(Pabradyphoto/iStock/Getty Images)

Bayer wins U.S. nod for Monsanto deal to create ag giant

Reading Time: 2 minutes Frankfurt/Washington | Reuters — Bayer won U.S. approval for its planned takeover of Monsanto after agreeing to sell about US$9 billion in assets, clearing a major hurdle for the US$62.5 billion deal that will create by far the largest seeds and pesticides maker. Makan Delrahim, who heads the U.S. Justice Department’s (DoJ) antitrust division, said […] Read more

(Bayer.com)

Singapore firm hikes Bayer stake in share sale

Reading Time: 2 minutes Frankfurt | Reuters — German drugmaker Bayer is raising three billion euros (C$4.67 billion) toward its planned US$62.5 billion takeover of seed and chemical firm Monsanto by selling a 3.6 per cent stake to Singapore’s state investment company Temasek. Bayer said it had struck a deal with Temasek under which it would issue shares with […] Read more